Free Trial Information
BioCentury | Nov 10, 2014
Financial News

Innocrin Pharmaceuticals completes venture financing

...Venture financing Raised: $14 million Investors: Novartis Option Fund; Lilly Ventures; Hatteras Funds; Intersouth Partners; Lurie Investments...
Read More
BioCentury | Jul 13, 2009
Financial News

Viamet completes venture financing

Viamet Pharmaceuticals Inc. , Morrisville, N.C. Business: Infectious, Inflammation, Cancer Date completed: 7/7/09 Type: Venture financing Raised: $18 million Investors: Novartis Option Fund; Lilly Ventures; Intersouth Partners; Hatteras Venture Partners; Lurie Investment Fund; Astellas Venture WIR...
Read More
BioCentury | Jul 8, 2009
Financial News

Viamet raises $18 million

Viamet Pharmaceuticals Inc. (Morrisville, N.C.) raised $18 million in a series B round led by Novartis Option Fund and Lilly Ventures. Existing investors Intersouth Partners; Hatteras Venture Partners; Lurie Investment Fund; and Astellas Venture Management...
Read More
BioCentury | Aug 25, 2008
Finance

Ebb & Flow

...which has $2.4 billion under management. Returning LPs included the State of Wisconsin Investment Board, Lurie Investments...
Read More
BioCentury | Sep 8, 2006
Financial News

RenaMed raises $40 million

...RenaMed (Lincoln, R.I.) raised $40 million in a mezzanine financing led by TVM Capital and Lurie Investments...
Read More
BioCentury | May 22, 2006
Finance

Ebb & Flow

...a series D round led by Bain Capital. Other investors included Allen & Co. and Lurie Investments...
Read More
BioCentury | May 17, 2006
Financial News

Nanosphere raises $57 million

...D round led by Bain Capital. Additional investors included Allen & Co. and founding investor Lurie Investments...
Read More
BioCentury | Dec 15, 2005
Financial News

Optimer raises $22.2 million

...by ProQuest Investments. New investors BB Biotech Ventures and Taiwan Global BioFund joined existing investors Lurie Investments...
Read More
BioCentury | Sep 30, 2005
Financial News

Nanosphere raises $10 million

...Ill.) raised $10 million in the second closing of a series C round led by Lurie Investments...
Read More
BioCentury | Jan 30, 2004
Financial News

Palatin raises $22.7 million

...in a private placement of 7 million shares at $3.25. Investors included Alexandra Investment Management; Lurie Investments...
Read More
Items per page:
1 - 10 of 14
BioCentury | Nov 10, 2014
Financial News

Innocrin Pharmaceuticals completes venture financing

...Venture financing Raised: $14 million Investors: Novartis Option Fund; Lilly Ventures; Hatteras Funds; Intersouth Partners; Lurie Investments...
Read More
BioCentury | Jul 13, 2009
Financial News

Viamet completes venture financing

Viamet Pharmaceuticals Inc. , Morrisville, N.C. Business: Infectious, Inflammation, Cancer Date completed: 7/7/09 Type: Venture financing Raised: $18 million Investors: Novartis Option Fund; Lilly Ventures; Intersouth Partners; Hatteras Venture Partners; Lurie Investment Fund; Astellas Venture WIR...
Read More
BioCentury | Jul 8, 2009
Financial News

Viamet raises $18 million

Viamet Pharmaceuticals Inc. (Morrisville, N.C.) raised $18 million in a series B round led by Novartis Option Fund and Lilly Ventures. Existing investors Intersouth Partners; Hatteras Venture Partners; Lurie Investment Fund; and Astellas Venture Management...
Read More
BioCentury | Aug 25, 2008
Finance

Ebb & Flow

...which has $2.4 billion under management. Returning LPs included the State of Wisconsin Investment Board, Lurie Investments...
Read More
BioCentury | Sep 8, 2006
Financial News

RenaMed raises $40 million

...RenaMed (Lincoln, R.I.) raised $40 million in a mezzanine financing led by TVM Capital and Lurie Investments...
Read More
BioCentury | May 22, 2006
Finance

Ebb & Flow

...a series D round led by Bain Capital. Other investors included Allen & Co. and Lurie Investments...
Read More
BioCentury | May 17, 2006
Financial News

Nanosphere raises $57 million

...D round led by Bain Capital. Additional investors included Allen & Co. and founding investor Lurie Investments...
Read More
BioCentury | Dec 15, 2005
Financial News

Optimer raises $22.2 million

...by ProQuest Investments. New investors BB Biotech Ventures and Taiwan Global BioFund joined existing investors Lurie Investments...
Read More
BioCentury | Sep 30, 2005
Financial News

Nanosphere raises $10 million

...Ill.) raised $10 million in the second closing of a series C round led by Lurie Investments...
Read More
BioCentury | Jan 30, 2004
Financial News

Palatin raises $22.7 million

...in a private placement of 7 million shares at $3.25. Investors included Alexandra Investment Management; Lurie Investments...
Read More
Items per page:
1 - 10 of 14